Captopril 25 mg tablets stability assessment in different primary packing materials
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Vigilância Sanitária em Debate |
DOI: | 10.22239/2317-269X.00945 |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945 |
Resumo: | Introduction: Packaging is used to provide protection and information, from the production to the administration of a formulation. It is essential to define the primary packaging, for keeping the therapeutic efficacy of drugs, safety of users and for protecting drugs from instability. Objectives: The main objective of this study was to assess the stability of captopril 25 mg tablets in different primary packaging materials. Method: The characterization (IR, DSC and physical tests) of the packaging materials used for captopril was carried out prior to the manufacture of tablets. Tablets were also characterized by physical-chemical analysis, comparative dissolution profile and stability studies. Results: The characterization of packaging materials was crucial for understanding the behavior of captopril when packed in each material. Materials with significant barrier, as blisters PVC/PVdC 90 g.m-² and hard aluminum and PVC/PE/PVdC and hard aluminum showed satisfactory results in a second stage, S2. On the contrary, lower barrier materials as blisters PVC/PVdC 40 g.m-² and hard aluminum did not present dissolution analysis S2. Conclusions: The aluminum strip presented the best results. And the batch in glass bottle, although packaged in excellent material, was disapproved in accelerated stability. |
id |
FIOCRUZ-9_577b09d8574a84b911f74429c8e674da |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/945 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
spelling |
Captopril 25 mg tablets stability assessment in different primary packing materialsAvaliação da estabilidade de comprimidos de captopril 25 mg em distintos materiais de embalagem primáriaPackagingStabilityCaptoprilTabletsEmbalagemEstabilidadeCaptoprilComprimidosIntroduction: Packaging is used to provide protection and information, from the production to the administration of a formulation. It is essential to define the primary packaging, for keeping the therapeutic efficacy of drugs, safety of users and for protecting drugs from instability. Objectives: The main objective of this study was to assess the stability of captopril 25 mg tablets in different primary packaging materials. Method: The characterization (IR, DSC and physical tests) of the packaging materials used for captopril was carried out prior to the manufacture of tablets. Tablets were also characterized by physical-chemical analysis, comparative dissolution profile and stability studies. Results: The characterization of packaging materials was crucial for understanding the behavior of captopril when packed in each material. Materials with significant barrier, as blisters PVC/PVdC 90 g.m-² and hard aluminum and PVC/PE/PVdC and hard aluminum showed satisfactory results in a second stage, S2. On the contrary, lower barrier materials as blisters PVC/PVdC 40 g.m-² and hard aluminum did not present dissolution analysis S2. Conclusions: The aluminum strip presented the best results. And the batch in glass bottle, although packaged in excellent material, was disapproved in accelerated stability.Introdução: A embalagem farmacêutica é utilizada para prover proteção e informação, da produção à administração de uma formulação. É essencial que seja feita uma avaliação criteriosa da embalagem destinada a um medicamento, a fim de manter a eficácia terapêutica e a segurança dos usuários e de proteger o medicamento de possíveis instabilidades. Objetivo: O objetivo principal deste estudo foi avaliar a estabilidade de comprimidos de captopril 25 mg em distintos materiais de embalagem primária. Método: A caracterização (IV, DSC e testes físicos) dos materiais de embalagem utilizados para o captopril foi realizada anteriormente à fabricação dos comprimidos. Os comprimidos foram caracterizados por análise físico-química, perfil de dissolução comparativo e estudos de estabilidade. Resultados: A caracterização da embalagem foi decisiva para compreender o comportamento do captopril quando acondicionado em cada material. Materiais com barreira expressiva, como blísteres de PVC/PVdC 90 g.m-² e alumínio duro e PVC/PE/PVdC e alumínio duro demonstraram resultados satisfatórios em um segundo segundo estágio (S2), enquanto materiais de menor barreira, como blísteres de PVC/PVdC 40 g.m-² e alumínio duro, não apresentaram análise de dissolução S2. Conclusões: O lote em strip de alumínio apresentou os melhores resultados. E o lote em frasco de vidro, apesar de acondicionado em excelente material, foi reprovado na estabilidade acelerada.Instituto Nacional de Controle de Qualidade em Saúde2017-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/94510.22239/2317-269X.00945Health Surveillance under Debate: Society, Science & Technology ; Vol. 5 No. 4 (2017): November; 54-67Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 5 Núm. 4 (2017): Noviembre; 54-67Vigil Sanit Debate, Rio de Janeiro; v. 5 n. 4 (2017): Novembro; 54-672317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/422https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/487Copyright (c) 2017 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessPaiva, Flávia Costa MendesRocha, Helvécio Vinicius Antunes2023-06-27T15:01:00Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/945Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:01Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Captopril 25 mg tablets stability assessment in different primary packing materials Avaliação da estabilidade de comprimidos de captopril 25 mg em distintos materiais de embalagem primária |
title |
Captopril 25 mg tablets stability assessment in different primary packing materials |
spellingShingle |
Captopril 25 mg tablets stability assessment in different primary packing materials Captopril 25 mg tablets stability assessment in different primary packing materials Paiva, Flávia Costa Mendes Packaging Stability Captopril Tablets Embalagem Estabilidade Captopril Comprimidos Paiva, Flávia Costa Mendes Packaging Stability Captopril Tablets Embalagem Estabilidade Captopril Comprimidos |
title_short |
Captopril 25 mg tablets stability assessment in different primary packing materials |
title_full |
Captopril 25 mg tablets stability assessment in different primary packing materials |
title_fullStr |
Captopril 25 mg tablets stability assessment in different primary packing materials Captopril 25 mg tablets stability assessment in different primary packing materials |
title_full_unstemmed |
Captopril 25 mg tablets stability assessment in different primary packing materials Captopril 25 mg tablets stability assessment in different primary packing materials |
title_sort |
Captopril 25 mg tablets stability assessment in different primary packing materials |
author |
Paiva, Flávia Costa Mendes |
author_facet |
Paiva, Flávia Costa Mendes Paiva, Flávia Costa Mendes Rocha, Helvécio Vinicius Antunes Rocha, Helvécio Vinicius Antunes |
author_role |
author |
author2 |
Rocha, Helvécio Vinicius Antunes |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Paiva, Flávia Costa Mendes Rocha, Helvécio Vinicius Antunes |
dc.subject.por.fl_str_mv |
Packaging Stability Captopril Tablets Embalagem Estabilidade Captopril Comprimidos |
topic |
Packaging Stability Captopril Tablets Embalagem Estabilidade Captopril Comprimidos |
description |
Introduction: Packaging is used to provide protection and information, from the production to the administration of a formulation. It is essential to define the primary packaging, for keeping the therapeutic efficacy of drugs, safety of users and for protecting drugs from instability. Objectives: The main objective of this study was to assess the stability of captopril 25 mg tablets in different primary packaging materials. Method: The characterization (IR, DSC and physical tests) of the packaging materials used for captopril was carried out prior to the manufacture of tablets. Tablets were also characterized by physical-chemical analysis, comparative dissolution profile and stability studies. Results: The characterization of packaging materials was crucial for understanding the behavior of captopril when packed in each material. Materials with significant barrier, as blisters PVC/PVdC 90 g.m-² and hard aluminum and PVC/PE/PVdC and hard aluminum showed satisfactory results in a second stage, S2. On the contrary, lower barrier materials as blisters PVC/PVdC 40 g.m-² and hard aluminum did not present dissolution analysis S2. Conclusions: The aluminum strip presented the best results. And the batch in glass bottle, although packaged in excellent material, was disapproved in accelerated stability. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-11-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed article" "Artículo revisado por pares" "Artigo avaliado pelos pares" |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945 10.22239/2317-269X.00945 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945 |
identifier_str_mv |
10.22239/2317-269X.00945 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/422 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/945/487 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 5 No. 4 (2017): November; 54-67 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 5 Núm. 4 (2017): Noviembre; 54-67 Vigil Sanit Debate, Rio de Janeiro; v. 5 n. 4 (2017): Novembro; 54-67 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1822182070465593344 |
dc.identifier.doi.none.fl_str_mv |
10.22239/2317-269X.00945 |